Indication
Hyperphosphatemia Related to Chronic Kidney Disease
1 clinical trial
2 products
Product
Ferric CitrateClinical trial
A 36-week, Single-Arm, Open-label Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney DiseaseStatus: Recruiting, Estimated PCD: 2025-01-01
Product
Ferric citrate